Sermorelin vs Semax
A comprehensive, data-driven comparison of Sermorelin (GHRH 1-29) and Semax. Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Sermorelin GHRH 1-29, GRF 1-29 | Semax |
|---|---|---|
| FDA Status | Withdrawn (off-label use continues) | Not submitted |
| Category | Growth Hormone | Cognitive Enhancement |
| Primary Use | Growth hormone deficiency and anti-aging | Cognitive enhancement and neuroprotection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $150 - $350/mo | $45 - $90/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 200-500mcg daily before bed | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH production | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Semax is generally more affordable ($45 - $90/mo) compared to Sermorelin ($150 - $350/mo).
- 2Sermorelin is administered via subcutaneous injection, while Semax uses nasal spray.
- 3They belong to different categories: Sermorelin (Growth Hormone) vs Semax (Cognitive Enhancement).
Which Is Better For...
Semax
More budget-friendly option with lower monthly costs
Semax
Fewer commonly reported side effects
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Sermorelin | $150 - $350/mo | Withdrawn (off-label use continues) | Various research labs |
| Semax | $45 - $90/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Sermorelin works via Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.
Sermorelin typically costs $150 - $350/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Sermorelin is not FDA-approved (Withdrawn (off-label use continues)). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Sermorelin include Injection site reactions, Flushing, Headache. Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Sermorelin is a bioidentical synthetic version of growth hormone releasing hormone (GHRH) consisting of the first 29 amino acids of the full 44-amino acid GHRH molecule. It was previously FDA-approved...
View Full Sermorelin GuideSemax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Sermorelin and Semax should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.